Table 2.
Symptoma N (%) |
APD (N = 60) |
Non-APD (N = 80) |
P between groups (chi-square) |
---|---|---|---|
Depression | 21 (35%) | 13 (16.2%) | 0.011 |
Cognitive dysfunction | 33 (55%) | 16 (20%) | < 0.001 |
Sleep Disorders | 12 (20%) | 8 (10%) | 0.096 |
Fatigue | 15 (25%) | 4 (5%) | 0.001 |
Hypertension | 18 (30%) | 29 (36.2%) | NS |
Cardiac abnormality | 14 (23.3%) | 22 (27.5%) | NS |
Diabetes Mellitus | 6 (10%) | 2 (2.5%) | NS |
Polyneuropathy/Neuropathy | 4 (6.7%) | 4 (5%) | NS |
Chronic Kidney Disease or Insufficiency | 2 (3.3%) | 0 | NS |
Chronic Liver Disease or Insufficiency | 1 (1.7%) | 1 (1.2%) | NS |
Chronic Pulmonary Disease | 2 (3.3%) | 1 (1.2%) | NS |
Skin Disease | 0 | 1 (1.2%) | NS |
Orthostatism | 3 (5%) | 2 (2.5%) | NS |
Chronic Gastrointestinal Disease | 3 (5%) | 4 (5%) | NS |
Any malignancy | 2 (3.3%) | 1 (1.2%) | NS |
Other | 16 (26.7%) | 17 (21.2%) | NS |
No comorbidity | 7 (11.7%) | 20 (25%) | NS |
In bold the significant values are reported; aMultiple entries were possible